AlloSource Announces Two-Year Shelf Life On ProChondrix CR Fresh Cryopreserved Osteochondral Allograft
Centennial, Colo. — March 12, 2019 — AlloSource®, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced that ProChondrix® CR now has a two-year shelf life based on the results of real-time testing. ProChondrix CR helps deliver the…
March 12, 2019Press ReleasesProChondrix CR,Allograft,Shelf Life
AlloSource Granted Patent for Proprietary Laser Cutting Enclosure
Centennial, Colo. — November 16, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, received U.S. patent 10,105,793, titled Enclosure for laser cutting of human tissue. This patent encompasses AlloSource’s method of producing…
November 16, 2018Press ReleasesProChondrix,osteochondral allograft,Allograft,Patent
AlloSource Releases AlloFuse Line Extentsion
Company adds AlloFuse Select CM, a cellular allograft matrix, to the AlloFuse portfolio Centennial, Colo. — August 1, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue, and cellular allografts to advance patient healing in surgical procedures and wound…
August 1, 2017Press ReleasesAlloFuse,Allograft,AlloSource,AlloFuse Select CM,bone
AlloSource’s Burn Skin AlloGraft Rebranded To Pureskin
Company to feature PureSkin at the American Burn Association Annual Meeting Centennial, Colo. — March 20, 2017 — AlloSource, one of the nation’s largest providers of burn skin, cartilage, bone, soft-tissue and cellular allografts for use in surgical procedures and burn and wound care to advance…
March 20, 2017Press ReleasesAmerican Burn Association,PureSkin,Allograft,Phoenix Society